Ketoprofen/Thiocolchicoside

酮洛芬/硫秋水仙苷

Report date: 2023/04/21 16:05:20

Base Information

Drug NameKetoprofen/Thiocolchicoside
Drug Alias Name硫秋水仙苷+酮洛芬
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonistsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsGamma-aminobutyric acid A receptorCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVenezuelaMexicoEgypt +[6] 
CombinationsYes ThiocolchicosideKetoprofen
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsLow Back Pain

Other Information

ATC CodeN/A
Related LinksN/A